top of page


Screenshot 2023-02-01 120746.jpg

Rambam Medtech, Israel

Pharmachal and tier-1 Israeli trauma hospital Rambam Health Care Campus are co-developing a new product that combines Pharmachal’s NOPAYNE mini-emulsion  drug delivery technology, lidocaine, and a novel peptide drug developed  at Rambam that has shown significant potential to speed up wound healing, coagulate bleeding, and encourage the formation of new blood vessels.

Screenshot 2023-02-01 121442.jpg

Magenta Investments, United Arab Emirates

Pharmachal is working with leading healthcare company Magenta Investments to distribute several products in the United Arab Emirates and GCC countries.

Screenshot 2023-02-01 122305.jpg
Fiona Stanley 2.jpg

Fiona Stanley Hospital, State Burns Service, Perth, Western Australia

Renowned burns specialist Professor Fiona Woods AO has supported the development of NOPAYNE as principal investigator and as a technical advisor to the company.

Fiona Stanley.jpg

Roosevelt Hospital, Paediatric Burns Unit, Guatemala City

Pharmachal has supplied burns products such as NOPAYNE to the Paediatric Burns Unit, led by Dr Lourdes Santiso.


Academic Institutions

bottom of page